VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $401,000 | -96.5% | 16,314 | -74.3% | 0.00% | -100.0% |
| Q3 2015 | $11,304,000 | -46.0% | 63,372 | -32.7% | 0.00% | -33.3% |
| Q2 2015 | $20,915,000 | +23.5% | 94,146 | +10.4% | 0.00% | 0.0% |
| Q1 2015 | $16,939,000 | -14.6% | 85,281 | -38.4% | 0.00% | 0.0% |
| Q4 2014 | $19,826,000 | -13.7% | 138,540 | -20.9% | 0.00% | -25.0% |
| Q3 2014 | $22,971,000 | +38.6% | 175,081 | +33.2% | 0.00% | +33.3% |
| Q2 2014 | $16,578,000 | +21.0% | 131,444 | +26.5% | 0.00% | +50.0% |
| Q1 2014 | $13,696,000 | +5.3% | 103,893 | -6.2% | 0.00% | 0.0% |
| Q4 2013 | $13,007,000 | +13.4% | 110,796 | +0.8% | 0.00% | 0.0% |
| Q3 2013 | $11,465,000 | +42.2% | 109,893 | +17.3% | 0.00% | 0.0% |
| Q2 2013 | $8,061,000 | – | 93,649 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |